By regulating the expression of several antioxidant enzymes, including HO-1, SOD, GPx, and CAT, Nrf-2 is thought to contribute to the mitigation of NAFLD [116]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.